Literature DB >> 19696737

Structural determinants for interaction of partial agonists with acetylcholine binding protein and neuronal alpha7 nicotinic acetylcholine receptor.

Ryan E Hibbs1, Gerlind Sulzenbacher, Jianxin Shi, Todd T Talley, Sandrine Conrod, William R Kem, Palmer Taylor, Pascale Marchot, Yves Bourne.   

Abstract

The pentameric acetylcholine-binding protein (AChBP) is a soluble surrogate of the ligand binding domain of nicotinic acetylcholine receptors. Agonists bind within a nest of aromatic side chains contributed by loops C and F on opposing faces of each subunit interface. Crystal structures of Aplysia AChBP bound with the agonist anabaseine, two partial agonists selectively activating the alpha7 receptor, 3-(2,4-dimethoxybenzylidene)-anabaseine and its 4-hydroxy metabolite, and an indole-containing partial agonist, tropisetron, were solved at 2.7-1.75 A resolution. All structures identify the Trp 147 carbonyl oxygen as the hydrogen bond acceptor for the agonist-protonated nitrogen. In the partial agonist complexes, the benzylidene and indole substituent positions, dictated by tight interactions with loop F, preclude loop C from adopting the closed conformation seen for full agonists. Fluctuation in loop C position and duality in ligand binding orientations suggest molecular bases for partial agonism at full-length receptors. This study, while pointing to loop F as a major determinant of receptor subtype selectivity, also identifies a new template region for designing alpha7-selective partial agonists to treat cognitive deficits in mental and neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696737      PMCID: PMC2760105          DOI: 10.1038/emboj.2009.227

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

1.  Orientation of alpha-neurotoxin at the subunit interfaces of the nicotinic acetylcholine receptor.

Authors:  S Malany; H Osaka; S M Sine; P Taylor
Journal:  Biochemistry       Date:  2000-12-19       Impact factor: 3.162

2.  Ligand-induced conformational changes in the acetylcholine-binding protein analyzed by hydrogen-deuterium exchange mass spectrometry.

Authors:  Jianxin Shi; Julia R Koeppe; Elizabeth A Komives; Palmer Taylor
Journal:  J Biol Chem       Date:  2006-02-16       Impact factor: 5.157

Review 3.  Partial agonists, full agonists, antagonists: dilemmas of definition.

Authors:  D Hoyer; H W Boddeke
Journal:  Trends Pharmacol Sci       Date:  1993-07       Impact factor: 14.819

4.  Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist.

Authors:  Roger L Papke; Hillary C Schiff; Brian A Jack; Nicole A Horenstein
Journal:  Neurosci Lett       Date:  2005-01-05       Impact factor: 3.046

Review 5.  The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).

Authors:  W R Kem
Journal:  Behav Brain Res       Date:  2000-08       Impact factor: 3.332

6.  Spectroscopic analysis of benzylidene anabaseine complexes with acetylcholine binding proteins as models for ligand-nicotinic receptor interactions.

Authors:  Todd T Talley; Samar Yalda; Kwok-Yiu Ho; Yitzhak Tor; Ferene S Soti; William R Kem; Palmer Taylor
Journal:  Biochemistry       Date:  2006-07-25       Impact factor: 3.162

7.  Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel.

Authors:  Cecilia Bouzat; Fernanda Gumilar; Guillermo Spitzmaul; Hai-Long Wang; Diego Rayes; Scott B Hansen; Palmer Taylor; Steven M Sine
Journal:  Nature       Date:  2004-08-19       Impact factor: 49.962

8.  Atomic interactions of neonicotinoid agonists with AChBP: molecular recognition of the distinctive electronegative pharmacophore.

Authors:  Todd T Talley; Michal Harel; Ryan E Hibbs; Zoran Radic; Motohiro Tomizawa; John E Casida; Palmer Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-13       Impact factor: 11.205

9.  N-terminal domains in mouse and human 5-hydroxytryptamine3A receptors confer partial agonist and antagonist properties to benzylidene analogs of anabaseine.

Authors:  Ran Zhang; Natalie A White; Ferenc S Soti; William R Kem; Tina K Machu
Journal:  J Pharmacol Exp Ther       Date:  2006-03-21       Impact factor: 4.030

10.  Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A resolution.

Authors:  Cosma D Dellisanti; Yun Yao; James C Stroud; Zuo-Zhong Wang; Lin Chen
Journal:  Nat Neurosci       Date:  2007-07-22       Impact factor: 24.884

View more
  83 in total

1.  Enhanced meta-analysis of acetylcholine binding protein structures reveals conformational signatures of agonism in nicotinic receptors.

Authors:  Spencer T Stober; Cameron F Abrams
Journal:  Protein Sci       Date:  2012-03       Impact factor: 6.725

2.  Defining the determinants of nicotine selectivity.

Authors:  Palmer Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

3.  Packing of the extracellular domain hydrophobic core has evolved to facilitate pentameric ligand-gated ion channel function.

Authors:  Cosma D Dellisanti; Sonya M Hanson; Lin Chen; Cynthia Czajkowski
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

4.  Subunit stoichiometry and arrangement in a heteromeric glutamate-gated chloride channel.

Authors:  Nurit Degani-Katzav; Revital Gortler; Lilach Gorodetzki; Yoav Paas
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-20       Impact factor: 11.205

5.  Creating an α7 nicotinic acetylcholine recognition domain from the acetylcholine-binding protein: crystallographic and ligand selectivity analyses.

Authors:  Akos Nemecz; Palmer Taylor
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

6.  Conformational remodeling of femtomolar inhibitor-acetylcholinesterase complexes in the crystalline state.

Authors:  Yves Bourne; Zoran Radić; Palmer Taylor; Pascale Marchot
Journal:  J Am Chem Soc       Date:  2010-11-19       Impact factor: 15.419

7.  Molecular actions of smoking cessation drugs at α4β2 nicotinic receptors defined in crystal structures of a homologous binding protein.

Authors:  Bert Billen; Radovan Spurny; Marijke Brams; René van Elk; Soledad Valera-Kummer; Jerrel L Yakel; Thomas Voets; Daniel Bertrand; August B Smit; Chris Ulens
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-22       Impact factor: 11.205

8.  Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors.

Authors:  Anton A Grishin; Hartmut Cuny; Andrew Hung; Richard J Clark; Andreas Brust; Kalyana Akondi; Paul F Alewood; David J Craik; David J Adams
Journal:  J Biol Chem       Date:  2013-10-07       Impact factor: 5.157

9.  A cation-π interaction at a phenylalanine residue in the glycine receptor binding site is conserved for different agonists.

Authors:  Stephan A Pless; Ariele P Hanek; Kerry L Price; Joseph W Lynch; Henry A Lester; Dennis A Dougherty; Sarah C R Lummis
Journal:  Mol Pharmacol       Date:  2011-01-25       Impact factor: 4.436

10.  Non-equivalent ligand selectivity of agonist sites in (α4β2)2α4 nicotinic acetylcholine receptors: a key determinant of agonist efficacy.

Authors:  Simone Mazzaferro; Federica Gasparri; Karina New; Constanza Alcaino; Manuel Faundez; Patricio Iturriaga Vasquez; Ranjit Vijayan; Philip C Biggin; Isabel Bermudez
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.